- T-Hub at BioAsia 2016 announced the launch of T-Hub Health Tech Innovation Accelerator – its first accelerator in the area of Health Tech
- Dr. Premanandini Satgunam LVPEI Institute awarded The BioAsia 2016 Innovation Award – a grant of Rs 60,000; at BioAsia 2016 Startup Showcase program
The 13th edition of BioAsia conducted the Startup Showcase program on the concluding day of the 3 day event.
Jay Krishnan, CEO T-Hub spoke about entrepreneurship, the need to support and encourage startups in India and the initiatives at T-Hub.
T-Hub – the largest incubator in the country announced the launch of its first accelerator in the area of Health Tech. To be named as – T-Hub Health Tech Innovation Accelerator, is in partnership with Merck and Microsoft Ventures. The accelerator will comprise of: a structured and steady execution plan, a growth plan based on experimentation and metrics and a well prioritized product plan. The startups operating from the accelerator will further receive mentorship from domain experts and will be connected to a platform to receive investment from institutional ventures.
Dr. Premanandini Satgunam of LVPEI was awarded The BioAsia 2016 Innovation Award. She also received a grant of Rs 60,000; at BioAsia 2016 Startup Showcase program.
The panelists during the startup showcase included: Nobel Laureate Prof. Ada Yonath, Weismann Institute, Israel, Mr. Vipin Antony, Mr. Suresh Challa President TiE Hyderabad, Mr. Shakthi Nagappan CEO BioAsia and Mr. Ramesh Loganathan, VP Products & MD Progress India and President HYSEA.
The startups which showcased at BioAsia 2016 were selected from the 150 applications received for the showcase program from the healthcare and innovation sector. The jury that included the startups included Mr. Safir Adeni, MD Ineda Ventures, Mr. PS Srikanth, Investment Director, Hyd Angels and many more.
The 5 startups that presented at the showcase were OurHealthMate (Read our exclusive feature here), BookMeds, Call Ambulance, Centre for Technology Assisted Reconstructive Surgery (CTARS) and Axio Biosolutions.